BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Thursday, February 5, 2026
Home » Newsletters » BioWorld Science

BioWorld Science

July 19, 2018

View Archived Issues

Fighting senescence boosts immunity

Read More

MANF rescues dopaminergic neurons in C. elegans alpha-synuclein models of Parkinson's disease

Read More

TAS-05567 selectively inhibits Syk kinase: potential treatment for autoimmune and allergic diseases

Read More

Immunity is for babies

Read More

SOM Biotech initiates phase IIa trial of repurposed drug

Read More

THX-160 shows promise in preclinical studies for acute and chronic pain

Read More

Selective PDE4D PET ligands developed to study depression and cognitive impairment

Read More

Orion Biotechnology earns grant to support development of microbicide candidate

Read More

Researchers unveil new biomarkers of treatment-free survival in CLL

Read More

Favorable review of safety data from second dose cohort in MAGE-A10 SPEAR T-cell study

Read More

Takeda and Ovid announce expansion of the clinical program for TAK-935

Read More

Topline data presented from phase III trial of tanezumab

Read More

Positive interim data presented from a phase II/III study of marzeptacog alfa

Read More

Beta cells make and secrete autoimmune peptides

Read More

Chinese phase III trial of GV-971 in Alzheimer's disease meets primary endpoint

Read More

RPL28 gene polymorphism tied to reduced survival in FOLFIRI-treated mCRC patients

Read More

KDDF grant will support evaluation of Hyleukin-7 with Keytruda in triple-negative breast cancer

Read More

Incyte studies INCB-054707 for hidradenitis suppurativa in phase II trial

Read More

Vyriad collaborates with Merck KGaA and Pfizer to study Voyager-V1 with avelumab

Read More

FDA approves Kisqali for HR-positive HER-negative advanced or metastatic breast cancer

Read More

Phase III study of subcutaneous vedolizumab in ulcerative colitis meets primary endpoint

Read More

Daiichi Sankyo and collaborator patent TNSALP inhibitors

Read More

Aquinnah Pharmaceuticals divulges TDP-43 aggregation inhibitors

Read More

Nampt inhibition with OT-82 shows promise in xenograft leukemia models

Read More

Incyte presents PD-1/PD-L1 interaction inhibitors

Read More

Global Blood Therapeutics patents EHMT2 inhibitors

Read More

Kissei Pharmaceutical synthesizes new TRPM8 antagonists

Read More

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for Feb. 4, 2025.
  • Today's news in brief

    Briefs
    BioWorld MedTech briefs for Jan. 30, 2026.
  • Art concept for medical research

    MicroRNAs in circulating extracellular vesicles as IPF biomarkers

    BioWorld Science
    MicroRNAs (miRNAs) are small noncoding RNAs gaining increasing attention due to their crucial role in gene expression regulation and influence in various cellular...
  • Illustration of brain with neuron receptor

    5-HT2R allosteric ligands attenuate cocaine use and seeking behavior

    BioWorld Science
    Serotonergic G-protein-coupled receptors (GPCRs), including the 5-HT2A receptor (5-HT2AR) and 5-HT2CR, are key regulators of cortical signaling pathways and...
  • Brain illustration

    MJFF grant supports Bexorg’s translational biomarker work

    BioWorld Science
    Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing